Get the Stockscreener App
0.6566
6.60%
-0.0464
After Hours:
.62
-0.0366
-5.57%
AEON Biopharma Inc. stock is traded at $0.6566, with a volume of 128.27K.
It is down -6.60% in the last 24 hours and down -21.83% over the past month.
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.
See More
Previous Close:
$0.703
Open:
$0.7281
24h Volume:
128.27K
Relative Volume:
0.18
Market Cap:
$7.42M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-9.18%
1M Performance:
-21.83%
6M Performance:
-93.26%
1Y Performance:
-99.12%
1-Day Range:
$0.63
$0.73
1-Week Range:
$0.63
$0.75
52-Week Range:
$0.375
$115.57
AEON Biopharma Inc. Stock (AEON) Company Profile
Name
AEON Biopharma Inc.
Sector
Industry
Phone
(949) 354-6499
Address
5 Park Plaza, Suite 1750, Irvine
Compare AEON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
0.6566 | 7.95M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.46 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.94 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.00 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
638.90 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
289.75 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-23 | Initiated | H.C. Wainwright | Buy |
AEON Biopharma Inc. Stock (AEON) Latest News
Visual analytics tools that track AEON Biopharma Inc. performanceFree AI-Powered Trade Planning with Indicators - Newser
What technical models suggest about AEON Biopharma Inc.’s comebackSecure Asset Flow and Trend Pattern Analysis - Newser
Published on: 2025-08-11 03:58:22 - Newser
Regression analysis insights on AEON Biopharma Inc. performanceProven Trading System with Consistent Gains - Newser
Applying chart zones and confluence areas to AEON Biopharma Inc.Momentum Stocks with Breakout Potential - Newser
Why AEON Biopharma Inc. stock attracts strong analyst attentionAI-Based Reversal Point Prediction Signal - Newser
Best data tools to analyze AEON Biopharma Inc. stockEarly Buy Opportunity with Chart Triggers - Newser
Predicting AEON Biopharma Inc. trend using moving averagesPredictive Short-Term Market Reversal Alerts - Newser
How AEON Biopharma Inc. stock performs during market volatilityHigh Reward Investment Strategy for Beginners - Newser
News impact scoring models applied to AEON Biopharma Inc.ROI Focused Setup With Drawdown Analysis - Newser
Chart overlay techniques for tracking AEON Biopharma Inc.Weekly Growth Portfolio Performance Summary - Newser
AEON Biopharma (AEON) to Release Quarterly Earnings on Monday - Defense World
What recovery options are there for AEON Biopharma Inc.Long-Term Investment Strategy Summary Guide - Newser
How to use a screener to detect AEON Biopharma Inc. breakoutsDaily Trade Monitor with Pattern Alerts - Newser
What to expect from AEON Biopharma Inc. in the next 30 daysAI Generated Buy/Sell Signal Forecast - Newser
Will AEON Biopharma Inc. stock go up soonFree Watchlist for Low Risk High Return - Newser
AEON Biopharma Inc. stock trend forecastFree Risk-Adjusted Picks With Exit Strategy - Newser
How strong is AEON Biopharma Inc. company’s balance sheetExceptional return forecasts - Jammu Links News
Is AEON Biopharma Inc. stock overvalued or undervaluedBreakthrough capital growth - Jammu Links News
What are analysts’ price targets for AEON Biopharma Inc. in the next 12 monthsCapitalize on momentum-driven investment opportunities - Jammu Links News
AEON Biopharma Inc. Stock Analysis and ForecastMaximize portfolio growth with strategic plans - Jammu Links News
Why is AEON Biopharma Inc. stock attracting strong analyst attentionSuperior stock growth - Jammu Links News
How many analysts rate AEON Biopharma Inc. as a “Buy”Free Bull & Bear Market Updates - Jammu Links News
How volatile is AEON Biopharma Inc. stock compared to the marketRapidly growing investment returns - Jammu Links News
Should I hold or sell AEON Biopharma Inc. stock in 2025Unprecedented market success - Jammu Links News
What are the latest earnings results for AEON Biopharma Inc.Free Stock Market Return Analysis - Jammu Links News
What catalysts could drive AEON Biopharma Inc. stock higher in 2025Robust financial gains - Jammu Links News
When is AEON Biopharma Inc. stock expected to show significant growthGrow your wealth steadily and securely - Jammu Links News
AEON Biopharma Inc. stock volume spike explainedDaily Breakout List with Smart Filters - Newser
Trend Reversal Possible in AEON Biopharma Inc. Charts IndicateGrowth Based Stock Signal Screener Updated - beatles.ru
AEON Biopharma Inc. Stock (AEON) Financials Data
There is no financial data for AEON Biopharma Inc. (AEON). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
AEON Biopharma Inc. Stock (AEON) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FISCHER JOST | Director |
May 20 '25 |
Buy |
0.51 |
60,000 |
30,360 |
206,785 |
| FISCHER JOST | Director |
May 19 '25 |
Buy |
0.50 |
50,000 |
24,940 |
146,785 |
3.70%
1.02%
Cap:
|
Volume (24h):